Literature DB >> 17235971

Cucurbitacins as Constituents of Wilbrandia ebracteata.

M R Farias1, E P Schenkel, R Mayer, G Rücker.   

Abstract

The methanolic extract from the roots of WILBRANDIA EBRACTEATA afforded, in addition to the known dihydrocucurbitacins B and E, dihydroisocucurbitacin B, Cucurbitacins B, D, E, G, H, P, and 22-deoxycucurbi-tacin D, four new compounds whose structures were elucidated as (20 R,24xi)-3)3beta,16alpha,20)24,25-pentahydroxy-10alpha-cucurbit-5-ene-2,11,22-trione (3- EPI-isocucurbitacin G) ( 8), (20 R,22xi)-2beta16a,20,22,25-pentahydroxy-10alpha-cucurbita-5,23 T-diene-3,11-dione ( 13), (20 R)-25-acetoxy-3,16alpha,20-trihydroxy-30- NOR-2-(beta- D-glucopyranosyloxy)-1,2,3,4,5,10-dehydrocucurbit-6-ene-11,22-dione ( 14), and dihydroisocucurbitacin B-3-glucoside ( 16).

Entities:  

Year:  1993        PMID: 17235971     DOI: 10.1055/s-2006-959668

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  5 in total

1.  Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways.

Authors:  Zhi-Ren Zhang; Ming-Xia Gao; Kai Yang
Journal:  Exp Ther Med       Date:  2017-06-06       Impact factor: 2.447

2.  Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Pimpicha Patmasiriwat; Frederick E Domann
Journal:  J Oncol       Date:  2012-05-28       Impact factor: 4.375

3.  Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.

Authors:  Mohammed Sikander; Bilal Bin Hafeez; Shabnam Malik; Abdulrhman Alsayari; Fathi T Halaweish; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

4.  Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells.

Authors:  Yanting Chai; Ke Xiang; Yezi Wu; Te Zhang; Ying Liu; Xuewen Liu; Weiguo Zhen; Yuan Si
Journal:  Med Sci Monit       Date:  2018-12-19

5.  The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.

Authors:  Moltira Promkan; Sumana Dakeng; Subhas Chakrabarty; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.